Gf Fund Management Co. Ltd. Supernus Pharmaceuticals, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,413 shares of SUPN stock, worth $45,894. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,413
Previous 1,159
21.92%
Holding current value
$45,894
Previous $41.9 Million
10.42%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SUPN
# of Institutions
300Shares Held
60.5MCall Options Held
22.3KPut Options Held
6K-
Black Rock Inc. New York, NY10.4MShares$338 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.15MShares$200 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.84MShares$157 Million2.47% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$93.5 Million0.03% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$85.4 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.74B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...